Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02QWO
|
||||
Former ID |
DNC013984
|
||||
Drug Name |
HOMOAROMOLINE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551362] | ||
Structure |
Download2D MOL |
||||
Formula |
C37H40N2O6
|
||||
Canonical SMILES |
CN1CCC2=CC(=C(C3=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7<br />=CC(=C(C=C7CCN6C)OC)O3)OC)O)OC
|
||||
InChI |
1S/C37H40N2O6/c1-38-14-12-24-19-31(42-4)33-21-27(24)28(38)17-23-8-11-30(41-3)32(18-23)44-26-9-6-22(7-10-26)16-29-35-25(13-15-39(29)2)20-34(43-5)36(40)37(35)45-33/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29+/m1/s1
|
||||
InChIKey |
YJRWQNIRFXVBRB-WDYNHAJCSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent dopamine transporter | Target Info | Inhibitor | [551362] | |
Pathway Interaction Database | Alpha-synuclein signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.